Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate

Table 1 Metabolic-associated fatty liver disease endorsement by societies, groups, and stakeholders

Type of endorsement	Endorsed by	Ref.
Guidelines	APASL	[25]
Guidelines	Egyptian EMRG group	[26]
Consensus statement	Middle East and North Africa group	[27]
View point (perspectives)	International nurse and allied health groups	[28]
Position statement	ALEH	[29]
Position statement	The Chinese Society of Hepatology	[30]
Position statement	ISTP	[31]
Position statement	Arabic Association for the Study of Diabetes and Metabolism	[32]
Consensus statement	Malaysian Society of Gastroenterology and Hepatology	[33]
Viewpoint (perspectives)	International leaders in regulatory science and drug development	[34]
Position statement	International representatives of patient advocacy groups	[35]
Letter of endorsement	Global multi-stakeholder from more than 135 countries worldwide	[36]
Editorial of endorsement	Spanish Society of Gastroenterology	[37]

APASL: Asian Pacific Association for the Study of the Liver; EMRG: Egyptian MAFLD Research Group; ISTIP: The International Society of Tropical Pediatrics; ALEH: The Latin American Association for the Study of the Liver.